Mortality rate and factors affecting the occurrence of Nosocomial Pneumonia in Prasat Hospital, Surin Province
Article Sidebar
Main Article Content
Abstract
Background: Pneumonia is the 5th leading cause of death worldwide according to the World Health Organization in 2021 and the 6th leading cause of death in Thailand according to Thai health statistics in 2020.
Objective: To study the mortality rate and factors associated with death from nosocomial pneumonia 28 days after treatment.
Methods: Retrospective cross-sectional study collecting medical records of patients diagnosed nosocomial pneumonia from January 1st, 2021, to December 31st, 2023. The data were collection prevalence death rate and analyzed factors associated with mortality.
Results: A review of medical records identified 110 patients. The majority of patients were male (70%). The mean age was 62 years. The most common pathogen was A. baumannii (multiple drug resistance) in 30.9%. The average duration of antibiotics was 9.7 days. The death rate after treatment within 28 days was 33 out of 110 (30%). The factors significantly affecting mortality include the duration of antibiotic treatment. Administering for less than 9 days (7 and 8 days) increases the likelihood of death by a factor of 2.3 ([95% CI, 1.29-4.27]; P=0.005) and intubation is performed for more than 5 days, the risk of death increases by 4.0 times ([95% CI, 1.06-15.37]; P=0.04).
Conclusion: The death rate for hospitalized patients with nosocomial pneumonia after treatment is 30% within 28 days. Factors that significantly increased deaths included administering antibiotics for less than 9 days and having intubation lasting more than 5 days.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World Health Organization. The top ten causes of death. [Internet]. [cited 2024 Nov 11]. Available from:URL: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
Thaihealthstat. [Internet]. Death rate of pneumonia; 2024. [cited 2024 Nov 11]. Available from: https://www.hiso.or.th/thaihealthstat/agegroup/overview_agegroup.php?a=6&tm=1&trm=2&td=1
Centers for Disease Control and Prevention. Guidelines for Prevention of Nosocomial Pneumonia. MMWR 1997;46(RR-1):1-79.
Tablan OC., Anderson LJ., Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003. [Internet]. [cited 2024 Nov 13]. Available from:URL: https://www.cdc.gov/infection-control/media/pdfs/Guideline-Healthcare-Associated-Pneumonia-H.pdf.
กรมควบคุมโรค. สำนักระบาดวิทยา กระทรวงสาธารณสุข. ประกาศเรื่องการป้องกันโรคและภัยสุขภาพที่เกิดขึ้นในช่วงฤดูหนาวของประเทศไทย ปี 2556 วันที่ 8 พฤศจิกายน 2566. [อินเทอร์เน็ต]. [สืบค้นเมื่อ 24 เม.ย. 2567]. ค้นได้จาก:URL: https://ddc.moph.go.th/uploads/publish/1501520231123052757.pdf.
Thaihealthstat. [Internet]. Death rate of pneumonia by age group; 2024. [cited 2024 Nov 14]. Available from: https://www.hiso.or.th/thaihealthstat/agegroup/index.php?a=6&ht=2&d=31
Rothan-Tondeur M, Meaume S, Girard L, Weill-Engerer S, Lancien E, Abdelmalak S, Rufat P, et al. Risk factors for nosocomial pneumonia in a geriatric hospital: a control-case one-center study. J Am Geriatr Soc 2003;51(7):997-1001. doi: 10.1046/j.1365-2389.2003.51314.x.
Hanson LC, Weber DJ, Rutala WA. Risk factors for nosocomial pneumonia in the elderly. Am J Med 1992;92(2):161-6. doi: 10.1016/0002-9343(92)90107-m.
Chawla R. Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control 2008;36(4 Suppl):S93-100. doi: 10.1016/j.ajic.2007.05.011.
Solis-Hernandez P S, Vidales-Reyes M, Garza-Gonzalez E, Guajardo-Alvarez G, Chavez-Moreno S, Camacho-Ortiz A. Hospital-Acquired Infections in Elderly Versus Younger Patients in an Acute Care Hospital. Int J Infect 2015;3(1):e32620. https://doi.org/10.17795/iji-32620.
Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study. Eur J Clin Microbiol Infect Dis 2017;36(11):1999-2006. doi: 10.1007/s10096-016-2703-z.
Sadigov A, Mamedova I, Mammmadov K. Ventilator-Associated Pneumonia and In-Hospital Mortality: Which Risk Factors may predict In-Hospital Mortality in Such Patients?. J Lung Health Dis 2019;3(4): 8-12. DOI:10.29245/2689-999X/2019/4.1157.
Dalhoff K, Ewig S, Abele-Horn M, Andreas S, Bauer TT, von Baum H, et al. Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatment. Dtsch Arztebl Int 2013;110(38):634-40. doi: 10.3238/arztebl.2013.0634.
Werarak P, Kiratisin P, Thamlikitkul V. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance. J Med Assoc Thai 2010;93 Suppl 1:S126-38. PMID: 20364567.
Sangsawang K, Luksamijarulkul P, Siri S, Pitikultang S. Incidence of nosocomial pneumonia and causative bacteria among chronically ill patients admitted in a general hospital. Chula Med J 2017;61(5):563–76.
Kumar ST, Yassin A, Bhowmick T, Dixit D. Recommendations From the 2016 Guidelines for the Management of Adults With Hospital-Acquired or Ventilator-Associated Pneumonia. P T 2017;42(12):767-72.PMID: 29234216
Centers for Disease Control and Prevention. Ventilator-associated pneumonia. [Internet]. 2003. [cited 2024 Nov 14]. Available from:URL: https://www.cdc.gov/healthcare-associated-infections/about/index.html.
Department of Disease Control Ministry of Public Health. [Internet]. Mortality rate. 2023. [cited 2024 Dec 10]. Available from:URL: http://elearningboe.moph.go.th/moodle/pluginfile.php/300/mod_resource/content/2/ep2_measure1_of_epid.pdf.
